Search by CAS No , Chemical Name or Molecular Formula
Long Term Storage
Off-White to Pale Orange Solid
"Oxcarbazepine is an anticonvulsant drug primarily used in the treatment of epilepsy. There is some evidence for oxcarbazepine as a mood-stabilizing agent and thus, it can be used as add-on therapy for bipolar disorder in patients that have failed or are unable to tolerate approved treatments.
Common side effects include nausea, vomiting, dizziness, drowsiness, headache, double vision and trouble with walking. Although not common, anaphylaxis may occur. Due to its structural similarities to carbamazepine there is approximately a 25\u201330% chance of cross-reactivity between the two medications.
Oxcarbazepine is marketed as Trileptal by Novartis and available in some countries as a generic drug. There is also an extended-release formulation marketed as Oxtellar XR by Supernus Pharmaceuticals.",""
It is an anticonvulsant and mood-stabilizing drug, used primarily in the treatment of epilepsy.
Mazza, Salvatore (2007-04-01); dailymed.nlm.nih.gov. Retrieved 2015-11-11.
We normally respond within 8 hours.
This page contains information about Oxcarbazepine Cas # 28721-07-5 and its API Standards.
Oxcarbazepine Oxcarbazepine Worldwide Suppliers of Oxcarbazepine https://www.clearsynth.com/en/CSO30723.html API Standards Clearsynth 28721-07-5
Regular price: $100 In stock
Product rating: 9 Oxcarbazepine based on 20 ratings
Keywords: API Standards 10,11-Dihydro-10-oxo-5h-dibenz[b,f]azepine5H-dibenzo[b,f]azepine-5carboxamide. CS-O-30723 Oxcarbazepine Oxcarbazepine 28721-07-5 252.27 C15H12N2O2
Internal standard, Internal standard Oxcarbazepine, HPLC-MS method validation, HPLC-MS method validation Oxcarbazepine, LC-MS-MS method validation, LC-MS-MS method validation Oxcarbazepine, Deuterated internal standard, Deuterated internal standard Oxcarbazepine, Deuterated Oxcarbazepine, Deuterium labeled Oxcarbazepine, Quantitative bioanalytical methods, Quantitative bioanalytical methods Oxcarbazepine, Blood samples Oxcarbazepine, Blood concentrations, Heavy drugs, Analysis, Analysis Oxcarbazepine, Clinical diagnostic, Clinical diagnostic Oxcarbazepine, Dosing Oxcarbazepine, Analytical method development, Internal standard method.
CLEARSYNTH CANADA INC.
2395 Speakman Drive,
Lab: 1001, Mississauga, ON,
Canada L5K 1B3
T : +1-289-729-0060
CLEARSYNTH RESEARCH CENTRE
Plot No. 177, IDA, Mallapur,
T : +91-40-27155481
CLEARSYNTH LABS LTD
17, Lotus Business Park,
Andheri (W), Mumbai - 400053
T : +91-22-45045945